Clinical Trial Results: A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating high-dose ascorbate in pancreatic cancer has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Neoplasms

Drugs mentioned

• High-dose ascorbate (ascorbic acid)

Snippet

Sponsor: University of Iowa | Conditions: Pancreatic Neoplasms, Cancer of Pancreas | Phase 2 | Status: COMPLETED | Results posted: 2026-07-23